News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY)'s Reluctance To Share Money With Shareholders Raises M&A Questions


1/30/2014 6:52:46 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Roche offered shareholders a lower-than-expected dividend payout after reporting an 18 percent rise in full-year net profit, potentially a sign the Swiss pharmaceuticals group might be keeping its cash for deals. Roche - the world's largest maker of cancer drugs - has a track record of solid profit growth prompting expectations of a more generous dividend, share buyback or M&A. It said on Thursday it planned to pay a dividend of 7.80 Swiss francs per share, up 6 percent over the previous year, and would keep hiking payouts. But this fell short of the mean estimate of 7.98 Swiss francs in a Reuters poll.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters

comments powered by Disqus
Reuters
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES